CPT1A-KCNG1 Fusion FISH Probe
The CPT1A-KCNG1 Fusion FISH Probe is used to confirm a fusion of the CPT1A and KCNG1 genes. The fusion of the CPT1A and KCNG1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
CPT1A-KCNG1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-RERE | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-REOR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-REGO | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-REGR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-REAQ | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-ORRE | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-OROR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-ORGO | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-ORAQ | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GORE | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GOOR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GOGO | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GOGR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GOAQ | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GRRE | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GROR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GRGO | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GRGR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-GRAQ | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-AQRE | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-AQOR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-AQGO | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-AQGR | 20 (40 μL) | 200 μL | ||
CPT1A-KCNG1-20-AQAQ | 20 (40 μL) | 200 μL |
CPT1A Gene Summary
The mitochondrial oxidation of long-chain fatty acids is initiated by the sequential action of carnitine palmitoyltransferase I (which is located in the outer membrane and is detergent-labile) and carnitine palmitoyltransferase II (which is located in the inner membrane and is detergent-stable), together with a carnitine-acylcarnitine translocase. CPT I is the key enzyme in the carnitine-dependent transport across the mitochondrial inner membrane and its deficiency results in a decreased rate of fatty acid beta-oxidation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Carnitine Palmitoyltransferase 1A
Chromosome: CHR11: 68522087 -68609399
Locus: 11q13.3
KCNG1 Gene Summary
Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily G. This gene is abundantly expressed in skeletal muscle. Multiple alternatively spliced transcript variants have been found in normal and cancerous tissues. [provided by RefSeq, Jul 2008]
Gene Name: Potassium Voltage-gated Channel Modifier Subfamily G Member 1
Chromosome: CHR20: 49620192 -49639675
Locus: 20q13.13
Gene Diseases
The CPT1A KCNG1 Fusion has been associated with the following diseases:
Disease Name |
---|
Breast Invasive Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|